Table 3.

General linear mixed-effect model of biofilm viability

	Fluorescence
Predictors	Estimates	std. Error	std. Beta	standardized std. Error	p
(Intercept)	6238.68	861.46	0.02	0.31	***
group [T1]	199.56	139.46	0.07	0.05	ns
same strain [Yes]	−1097.29	684.77	−0.39	0.25	ns
CRS phenotype [CRSwNP]	1006.30	957.54	0.36	0.34	ns
aspirin sensitivity [1]	1486.26	905.63	0.53	0.33	ns
asthma [1]	−497.92	696.91	−0.18	0.25	ns
Log(concentration)	−258.91	14.52	−0.17	0.01	***
antibiotic [clarithromycin]	−913.07	100.05	−0.33	0.04	***
antibiotic [clindamycin]	−940.96	100.05	−0.34	0.04	***
antibiotic [doxycycline]	−2226.13	100.05	−0.80	0.04	***
antibiotic [erythromycin]	465.69	100.05	0.17	0.04	***
antibiotic [gentamicin]	−234.94	100.05	−0.08	0.04	*
antibiotic [mupirocin]	−1526.72	100.05	−0.55	0.04	***
group [T1] × same strain [Yes]	1487.72	115.88	0.53	0.04	***
group [T1] × CRS phenotype [CRSwNP]	−166.77	161.03	−0.06	0.06	ns
Random Effects
σ2	3403460.07
τ00 id	3239247.47
N id	34
Observations	4760
Marginal R2/Conditional R2	0.193/0.587
*P<0.05 **P<0.01 ***P<0.001